Lyra Therapeutics, Inc. (LYRA)
OTCMKTS · Delayed Price · Currency is USD
0.4401
-0.0599 (-11.98%)
At close: Mar 18, 2026
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $781.13 thousand as of March 19, 2026. Its market cap has decreased by -93.86% in one year.
Market Cap
781.13K
Enterprise Value
10.11M
Revenue
600.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.44
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from 230.14M to 781.13K, a decrease of -99.66%. That is a compound annual growth rate of -61.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 887.44K | -83.77% |
| Dec 31, 2025 | 5.47M | -59.54% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eastgate Biotech | 1.06M |
| Halberd | 1.05M |
| Emmaus Life Sciences | 1.02M |
| Protagenic Therapeutics | 981.95K |
| EV Biologics | 848.71K |
| THC Farmaceuticals | 834.05K |
| Oncology Pharma | 773.26K |
| Lipella Pharmaceuticals | 743.96K |